C4 Therapeutics Inc (CCCC) Stock: Evaluating the Market Performance

23h ago, source: newsheater

To wrap up, the performance of C4 Therapeutics Inc (CCCC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the ...

CCCC C4 Therapeutics, Inc.

8d ago, source: Seeking Alpha

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative ...

C4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?

1mon ago, source: Hosted on MSN

When C4 Therapeutics, Inc. CCCC reports fourth-quarter and full-year 2023 results, investors will primarily focus on pipeline updates. The company has a decent track record of beating on earnings ...

C4 Therapeutics Inc Ordinary Shares

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates

1mon ago, source: Zacks.com on MSN

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to loss of $0.76 per share a year ago.

Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)

22d ago, source: Yahoo Finance

Meridian Small Cap Growth Fund featured stocks like C4 Therapeutics, Inc. (NASDAQ:CCCC) in the Q4 2023 investor letter. Headquartered in Watertown, Massachusetts, C4 Therapeutics, Inc. (NASDAQ ...

C4 Dips On Release Of Data

10d ago, source: InvestingChannel on MSN

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares staggered Monday. The Watertown, Mass.-based company, a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science ...

New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)

1mon ago, source: Yahoo Finance

C4 Therapeutics, Inc. (NASDAQ:CCCC) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. Consensus estimates suggest ...

C4 Therapeutics Inc Ordinary Shares

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

C4 Therapeutics Inc.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

C4 Therapeutics Inc.

2mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...